These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20190560)

  • 1. Certolizumab pegol.
    Goel N; Stephens S
    MAbs; 2010; 2(2):137-47. PubMed ID: 20190560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Certolizumab pegol: a new biologic targeting rheumatoid arthritis.
    Patel AM; Moreland LW
    Expert Rev Clin Immunol; 2010 Nov; 6(6):855-66. PubMed ID: 20979550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PEGylated Fab' fragment against tumor necrosis factor for the treatment of Crohn disease: exploring a new mechanism of action.
    Bourne T; Fossati G; Nesbitt A
    BioDrugs; 2008; 22(5):331-7. PubMed ID: 18778114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Certolizumab pegol in Crohn's disease.
    Patel VK; Ghosh S
    Drugs Today (Barc); 2008 Nov; 44(11):837-44. PubMed ID: 19180261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Certolizumab pegol: a TNF-{alpha} antagonist for the treatment of moderate-to-severe Crohn's disease.
    Smith LS; Nelson M; Dolder CR
    Ann Pharmacother; 2010 Feb; 44(2):333-42. PubMed ID: 20118143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Certolizumab pegol: in rheumatoid arthritis.
    Duggan ST; Keam SJ
    BioDrugs; 2009; 23(6):407-17. PubMed ID: 19894782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Certolizumab pegol.
    Melmed GY; Targan SR; Yasothan U; Hanicq D; Kirkpatrick P
    Nat Rev Drug Discov; 2008 Aug; 7(8):641-2. PubMed ID: 18670430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Certolizumab pegol: new drug. As a last resort in Crohn's disease: continue to use other TNF alpha inhibitors.
    Prescrire Int; 2009 Jun; 18(101):108-10. PubMed ID: 19637418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Certolizumab pegol: in Crohn's disease.
    Blick SK; Curran MP
    BioDrugs; 2007; 21(3):195-201; discussion 202-3. PubMed ID: 17516714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Certolizumab pegol for the management of Crohn's disease in adults.
    Rivkin A
    Clin Ther; 2009 Jun; 31(6):1158-76. PubMed ID: 19695385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice.
    Punzi L; Lapadula G; Mathieu A
    BioDrugs; 2014 Apr; 28 Suppl 1():S25-37. PubMed ID: 24687236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Certolizumab pegol: a review of its use in patients with axial spondyloarthritis or psoriatic arthritis.
    Dhillon S
    Drugs; 2014 Jun; 74(9):999-1016. PubMed ID: 24919863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pegylation of biological molecules and potential benefits: pharmacological properties of certolizumab pegol.
    Pasut G
    BioDrugs; 2014 Apr; 28 Suppl 1():S15-23. PubMed ID: 24687235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Certolizumab pegol: a review of its use in the management of rheumatoid arthritis.
    Deeks ED
    Drugs; 2013 Jan; 73(1):75-97. PubMed ID: 23338540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of patients with destructive arthritis with certolizumab pegol].
    Schmeiser T; Müller-Ladner U
    Z Rheumatol; 2010 Sep; 69(7):653-6. PubMed ID: 20532790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Certolizumab pegol].
    Delgado Frías E; Díaz González JF
    Reumatol Clin; 2011 Mar; 6S3():S7-11. PubMed ID: 21794764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAPID and FAST4WARD trials: certolizumab pegol for rheumatoid arthritis.
    Ramiro S; van Tubergen AM; Landewé RB
    Expert Rev Clin Immunol; 2010 Sep; 6(5):713-20. PubMed ID: 20828279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study.
    Fleischmann R; Vencovsky J; van Vollenhoven RF; Borenstein D; Box J; Coteur G; Goel N; Brezinschek HP; Innes A; Strand V
    Ann Rheum Dis; 2009 Jun; 68(6):805-11. PubMed ID: 19015206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug approvals: '08 in review. Certolizumab pegol (Cimzia).
    Laustsen G; Carrillo F; Johnson J; Smith C
    Nurse Pract; 2009 Feb; 34(2):26-7. PubMed ID: 19155878
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintenance therapy with certolizumab pegol for Crohn's disease.
    Schreiber S; Khaliq-Kareemi M; Lawrance IC; Thomsen OØ; Hanauer SB; McColm J; Bloomfield R; Sandborn WJ;
    N Engl J Med; 2007 Jul; 357(3):239-50. PubMed ID: 17634459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.